Alzheimer’s disease accounts for 60 to 70 percent of dementia cases, according to World Health Organization data, yet the terms dementia and Alzheimer’s are frequently used interchangeably in everyday conversation. While Alzheimer’s is the most common form of cognitive decline, experts emphasize that dementia is an umbrella term encompassing a wide variety of distinct neurological … Read more
Glucosamine, a popular over-the-counter supplement widely used for arthritis and joint pain, is linked to a 25% higher risk of progression from mild cognitive impairment to Alzheimer’s disease, according to a study published in Nature Metabolism. University of Florida researchers analyzed patient data from 2012 to 2024, finding that the supplement may accelerate cognitive decline … Read more
Eli Lilly’s anti-amyloid drug donanemab, marketed as Lormalzi, has received regulatory approval in India, offering a new treatment pathway for patients with early symptomatic Alzheimer’s disease. Despite its potential to slow cognitive decline, neurologists, including Dr. Sudhir Kumar of Apollo Hospitals Hyderabad, warn that high costs, diagnostic barriers, and modest clinical benefits may limit its … Read more
The Rising Tide of Early-Onset Alzheimer’s and the Fight for Access to Care Alzheimer’s disease is often associated with later life, but a growing number of individuals are being diagnosed in their 30s, 40s and 50s – a phenomenon known as early-onset Alzheimer’s. This presents unique challenges, not only for those affected and their families, … Read more
The Sleep-Dementia Connection: What the Latest Research Reveals As anyone who’s tossed and turned through a sleepless night knows, poor sleep impacts daily life. But could it also be linked to long-term cognitive decline? Recent research is increasingly pointing to a complex relationship between sleep quality and the risk of dementia, a topic explored in … Read more
The Dawn of Early Alzheimer’s Detection: A New Hope for Millions For decades, an Alzheimer’s diagnosis felt like a life sentence. But a growing wave of scientific advancements and a shift in focus towards early detection are rewriting that narrative. Physician Brent Beasley’s story, recently shared in the Wall Street Journal, exemplifies this change. Losing … Read more
Beyond Amyloid: The Rising Hope of Targeting Tau in Alzheimer’s and Beyond For decades, the fight against Alzheimer’s disease has largely focused on amyloid plaques – the sticky clumps of protein that accumulate in the brain. But a growing body of research suggests that another protein, tau, may be the more critical target. New findings … Read more
Unraveling Alzheimer’s: How Mapping the ‘Fuzzy Coat’ of Tau Protein Could Revolutionize Drug Development For decades, the hallmark of Alzheimer’s disease – the tangled clumps of Tau protein in the brain – has been a frustratingly elusive target for drug developers. Now, groundbreaking research from MIT is offering a new perspective, focusing not on the … Read more
The Dawn of a New Era in Alzheimer’s Detection: From Spinal Taps to Finger Pricks For decades, diagnosing Alzheimer’s disease has been a complex, often invasive, and delayed process. Relying heavily on expensive brain scans, cognitive assessments, and, in some cases, lumbar punctures (spinal taps), early detection – crucial for effective intervention – has remained … Read more
The Silent Threat: Alzheimer’s, Early Detection, and the Future of Brain Health Alzheimer’s disease, the most common form of dementia, is a progressive condition impacting memory, language, and cognitive functions. While a definitive cure remains elusive, a growing body of research highlights the critical importance of early detection and proactive lifestyle changes in mitigating its … Read more